VEGFA and infarction: In particular, we demonstrate that anti-Nogo-A antibodies (1) have similar pro-angiogenic effects as local VEGF treatment (2) do not increase vascular permeability in the peri-infarction regions, (3) partially reverse the VEGF induced blood vessel leakage when co-administrated.